Therefore, determining the relationship between HIF-1α activation and the survival potential of canine lymphoma cells under hypoxic conditions may provide insight into tumorigenesis and provide medically valuable information for the treatment of both NHL and canine lymphoma. The gene discussed is HIF1A; the disease is non-Hodgkin lymphoma.